Document is current
Any future updates will be listed below
-
Authors
Tamme, Kadri
Acosta, Stefan
Biloslavo, Alan
Björck, Martin
Casian, Dumitru
Damaskos, Dimitrios
Forbes, Alastair
Kase, Karri
Kisand, Kalle
Lakbar, Ines
Mihnovitš, Vladislav
Murruste, Marko
Mändul, Merli
Nuzzo, Alexandre
Padar, Martin
Starkopf, Joel
Visconti, Diego
Reintam Blaser, Annika
-
Funding
Funding for this research was provided by:
Eesti Teadusagentuur (PRG1255, PRG1255, PRG1255, PRG1255, PRG1255, PRG1255, PRG1255, PRG1255)
- License Information
-
More Information
Article History
Received: 19 March 2024
Accepted: 24 June 2024
First Online: 3 July 2024
Declarations
:
: Currently the study has been approved by the Research Ethics Committee of the University of Tartu, (Approval No. 386/T-11) to proceed with a delayed consent process. Participating sites will obtain approval from local ethics committees, local approaches regarding delayed consent, consent by next-of-kin and waiver of consent may vary.
: Not applicable.
: ARB has received speaker or consultancy fees from Nestlé, VIPUN Medical, Nutricia and Fresenius Kabi, and is holding a grant from Estonian Research Council (PRG1255). AF has received speaker fees from B Braun and Fresenius Kabi. AN has received speaker or consultancy fees from Abbvie and Janssen, research funding from MSD-Avenir, and PhD grants from Fondation de l’Avenir and SNFGE. KT, SA, AB, MB, DC, DD, KKa, KKi, IL, VM, MMu, MMä, MP, JS and DV declare no conflicts of interest.
